U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159074) titled 'Repurposing Tilmanocept for Cardiac Sarcoidosis' on Aug. 20.
Brief Summary: The purpose of this study is to see if Tc 99m Tilmanocept SPECT/CT imaging can be used to identify cardiac sarcoidosis.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Cardiac Sarcoidosis
Intervention:
DRUG: Tc 99m tilmanocept
150 mcg containing 10 mCi of Tc 99m tilmanocept will be administered through an IV route of injection. SPECT-CT imaging will then be performed.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Duke University
Published by HT Digital Content Services with permission from Health Daily Digest....